Mileage matters: long-distance performance of CARs in multiple myeloma
Journal for ImmunoTherapy of Cancer · 2025
DOI: 10.1136/jitc-2025-012730 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2025. Verfasst von Eric M Jurgens und 2 weiteren Autor:innen. Beteiligte Einrichtung: Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Multiple Myeloma, B-Cell Maturation Antigen, Receptors, Chimeric Antigen, Neoplasm Recurrence, Local. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, Deutsche Forschungsgemeinschaft, International Myeloma Society.
Abstract (Originalsprache)
Targeting B-cell maturation antigen with chimeric antigen receptor (CAR) T-cells is a new standard of care in relapsed/refractory multiple myeloma (RRMM). However, long-term data have currently remained sparse. In a recent study published in the Journal for ImmunoTherapy of Cancer by Jin et al , authors reported on a large cohort of 141 patients with a median follow-up of 20.2 months. They found an overall response rate of 90.1% with 48.2% achieving a complete response. The median progression-free survival was 15.2 months, and the 4-year overall survival rate was 63.2%. In the current article, we summarize the published long-term data from clinically approved and investigational CAR T-cells for RRMM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Memorial Sloan Kettering Cancer Center, New York, New York, USA maximilian.merz@medizin.uni-leipzig.de.
- Leipzig University, Leipzig, Saxony, Germany.
Förderung
- NCI NIH HHS
- Deutsche Forschungsgemeinschaft
- International Myeloma Society
- EU HORIZON
Zitieren
APA
Jurgens, E. M., Usmani, S. Z., & Merz, M. (2025). Mileage matters: long-distance performance of CARs in multiple myeloma. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2025-012730
Vancouver
Jurgens EM, Usmani SZ, Merz M. Mileage matters: long-distance performance of CARs in multiple myeloma. Journal for ImmunoTherapy of Cancer. 2025. doi:10.1136/jitc-2025-012730
BibTeX
@article{Jurgens2025,
author = {Jurgens, Eric M and Usmani, Saad Z and Merz, Maximilian},
title = {Mileage matters: long-distance performance of CARs in multiple myeloma},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2025},
doi = {10.1136/jitc-2025-012730}
}
EUVIMED